While OS is still the king of the oncology endpoints, experts note it may soon be phased out due to the introduction of ...

Security can’t be added as an afterthought. Here’s why risk assessment needs to be built into DevOps from the start to make ...

SOL-1 superiority trial continues to demonstrate outstanding patient retention and protocol adherence, with no new or ...

The U.S. Food and Drug Administration has approved Opzelura cream 1.5% (ruxolitinib) for children ages 2 to 11 years with ...

Only 1% of companies say they’re completely ready to be assessed through the Cybersecurity Maturity Model Certification (CMMC ...

Patients had less clinical worsening when treated with this “wonder drug,” as one doctor called it, within a year of ...

Elastic (NYSE: ESTC), the Search AI Company, announced that Elastic Security earned Certified status in the AV-Comparatives Endpoint Prevention and Response (EPR) Test 2025, delivering 99.3% ...

AI-generated fraud is no longer theoretical. Here's a 90-day action plan to help business leaders protect identity, build ...

Results from only the third randomized controlled trial on the modern use of low-dose radiation therapy for osteoarthritis ...

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated ...